DOI: https://doi.org/10.14710/jksa.27.6.250-257

In Silico Analysis for Exploring the Potential Inhibitors Against Breast Cancer (MCF7) Using Curcumin Analogue Compounds

1Sekolah Tinggi Ilmu Farmasi (STIFAR), Pekanbaru, Riau, Indonesia

2Department of Chemistry, Faculty of Mathematics and Natural of Mathematics and Natural Sciences, Universitas Riau, Riau, 28293, Indonesia

Received: 10 Oct 2023; Revised: 22 May 2024; Accepted: 22 May 2024; Published: 30 Jun 2024.
Open Access Copyright 2024 Jurnal Kimia Sains dan Aplikasi under http://creativecommons.org/licenses/by-sa/4.0.

Citation Format:
Cover Image
Abstract
Breast cancer is one of the most problematic diseases in the world. Currently, there are no potential vaccines for the treatment of this disease. Therefore, finding effective compounds, such as curcumin analogs, is crucial to inhibit breast cancer. Forty-five synthesized curcumin analogs were tested on the MCF7 cell line using the MTT assay. It was shown that nine curcumin compounds, Cpd 5, Cpd 9, Cpd 17, Cpd 18, Cpd 21, Cpd 25, Cpd 28, Cpd 32, and Cpd 45, had better inhibitory activities against breast cancer. Furthermore, in silico analysis was developed using 2D and 3D QSAR models with high predictive ability, with an r2 value of 0.834. In addition, based on molecular docking, molecular dynamics, and pharmacophore results, it was shown that these nine compounds had the lowest binding free energy and were also stable during the simulation. The presence of methoxy groups, hydrogen bond donors, and aromatic ring features are the main factors that enhance the biological activity of curcumin analogs. Therefore, these compounds could serve as references for the next stage of drug design.

Note: This article has supplementary file(s).

Fulltext View|Download |  Research Instrument
In Silico Analysis for Exploring the Potential Inhibitors Against Breast Cancer (MCF7) Using Curcumin Analogue Compounds
Subject curcumin; docking; molecular dynamic; pharmacophore; QSAR
Type Research Instrument
  Download (712KB)    Indexing metadata
Keywords: curcumin; docking; molecular dynamic; pharmacophore; QSAR

Article Metrics:

Article Info
Section: Research Articles
Language : EN
Recent articles
In Silico Analysis for Exploring the Potential Inhibitors Against Breast Cancer (MCF7) Using Curcumin Analogue Compounds Synthesis of Bromo Eugenol Derivatives with Molecular Bromine Effect of Precursors Concentration on The Optical and Photoelectrochemical Properties of Bi₂S₃/TiO₂ Nanotubes Arrays Photoanode Synthesized by the SILAR Technique Study on the Upgrading Citronella (Cymbopogon nardus L.) Oil Isolation Using Microwave Assisted Hydro-distillation Method More recent articles
Most cited articles
Pemanfaatan Montmorillonit Terpilar Al-Cr pada Adsorpsi Zat Warna Rhodamin B dengan Variasi Massa Adsorben dan Waktu Adsorpsi Utilization of Rice Husk Cellulose as a Magnetic Nanoparticle Biocomposite Fiber Source for the Absorption of Manganese (Mn2+) Ions in Peat Water Pengaruh Pemerangkapan Enzim Alkalin Fosfatase ke dalam Silika dari Abu Sekam Padi terhadap Aktivitas Enzimatiknya Analisis Pangan: Penentuan Angka Peroksida dan Asam Lemak Bebas pada Minyak Kedelai dengan Variasi Menggoreng Isolation of Flavonoid Compounds from Eceng Gondok (Eichhornia crassipes) and Antioxidant Tests with DPPH (1,1-Diphenyl-2-Picrylhydrazyl) Method More cited articles
  1. Amena Ali, Abuzer Ali, Abu Tahir, Md. Afroz Bakht, Salahuddin, Mohamed Jawed Ahsan, Molecular Engineering of Curcumin, an Active Constituent of Curcuma longa L. (Turmeric) of the Family Zingiberaceae with Improved Antiproliferative Activity, Plants, 10, 8, (2021), 1559 https://doi.org/10.3390/plants10081559
  2. Xinqiang Song, Mu Zhang, Erqin Dai, Yuan Luo, Molecular targets of curcumin in breast cancer (Review), Mol Med Rep, 19, 1, (2019), 23-29 https://doi.org/10.3892/mmr.2018.9665
  3. Ying-Bo Li, Jian-Li Gao, Zhang-Feng Zhong, Pui-Man Hoi, Simon Ming-Yuen Lee, Yi-Tao Wang, Bisdemethoxycurcumin suppresses MCF-7 cells proliferation by inducing ROS accumulation and modulating senescence-related pathways, Pharmacological Reports, 65, 3, (2013), 700-709 https://doi.org/10.1016/S1734-1140(13)71048-X
  4. Cheppail Ramachandran, Sonia Rodriguez, Reshma Ramachandran, PK Raveendran Nair, Hugo Fonseca, Ziad Khatib, Enrique Escalon, Steven J. Melnick, Expression Profiles of Apoptotic Genes Induced by Curcumin in Human Breast Cancer and Mammary Epithelial Cell Lines, Anticancer Research, 25, 5, (2005), 3293-3302
  5. Purusotam Basnet, Natasa Skalko-Basnet, Curcumin: An Anti-Inflammatory Molecule from a Curry Spice on the Path to Cancer Treatment, Molecules, 16, 6, (2011), 4567-4598 https://doi.org/10.3390/molecules16064567
  6. Yan Chen, Wenxiu Shu, Weihua Chen, Qing Wu, Hongli Liu, Guohui Cui, Curcumin, both Histone Deacetylase and p300/CBP-Specific Inhibitor, Represses the Activity of Nuclear Factor Kappa B and Notch 1 in Raji Cells, Basic & Clinical Pharmacology & Toxicology, 101, 6, (2007), 427-433 https://doi.org/10.1111/j.1742-7843.2007.00142.x
  7. Ajay Goel, Ajaikumar B. Kunnumakkara, Bharat B. Aggarwal, Curcumin as “Curecumin”: From kitchen to clinic, Biochemical Pharmacology, 75, 4, (2008), 787-809 https://doi.org/10.1016/j.bcp.2007.08.016
  8. Neni Frimayanti, Ihsan Ikhtiarudin, Rahma Dona, Tiara Tri Agustini, Fri Murdiya, Adel Zamri, A Computational Approach to Drug Discovery: Search for Chalcone Analogues as the Potential Candidates for Anti Colorectal Cancer (HT29), Walailak Journal of Science and Technology (WJST), 17, 2, (2018), 64-74 https://doi.org/10.48048/wjst.2020.5910
  9. Zintle Mbese, Vuyolwethu Khwaza, Blessing Atim Aderibigbe, Curcumin and Its Derivatives as Potential Therapeutic Agents in Prostate, Colon and Breast Cancers, Molecules, 24, 23, (2019), 4386 https://doi.org/10.3390/molecules24234386
  10. Fiona C. Rodrigues, N. V. Anil Kumar, Gangadhar Hari, K. S. R. Pai, Goutam Thakur, The inhibitory potency of isoxazole-curcumin analogue for the management of breast cancer: A comparative in vitro and molecular modeling investigation, Chemical Papers, 75, (2021), 5995-6008 https://doi.org/10.1007/s11696-021-01775-9
  11. Yum Eryanti, Tati Herlina, Adel Zamri, Siti Nadiah Abdul Halim, Yoshihito Shiono, Yana M. Syah, Khalijah Awang, Unang Supratman, 3,5-Bis(2-hydroxybenzylidene)piperidin-4-one, Molbank, 2014, 2, (2014), M825 https://doi.org/10.3390/M825
  12. Yum Eryanti, Adel Zamri, Neni Frimayanti, Hilwan Yuda Teruna, Unang Supratmman, Tati Herlina, Yoshihito Shiono, Synthesis, Structure-Activity Relationship, Docking and Molecular Dynamic Simulation of Curcumin Analogues Against HL-60 for Anti Cancer Agents (Leukemia), Oriental Journal of Chemistry, 33, 5, (2017), 2164-2172 http://dx.doi.org/10.13005/ojc/330503
  13. Philip Skehan, Ritsa Storeng, Dominic Scudiero, Anne Monks, James McMahon, David Vistica, Jonathan T. Warren, Heidi Bokesch, Susan Kenney, Michael R. Boyd, New Colorimetric Cytotoxicity Assay for Anticancer-Drug Screening, JNCI: Journal of the National Cancer Institute, 82, 13, (1990), 1107-1112 https://doi.org/10.1093/jnci/82.13.1107
  14. Yuni Elsa Hadisaputri, Tatsuya Miyazaki, Shigemasa Suzuki, Takehiko Yokobori, Tsutomu Kobayashi, Naritaka Tanaka, Takanori Inose, Makoto Sohda, Hiroyuki Kuwano, TNFAIP8 Overexpression: Clinical Relevance to Esophageal Squamous Cell Carcinoma, Annals of Surgical Oncology, 19, (2012), 589-596 https://doi.org/10.1245/s10434-011-2097-1
  15. Jie Dong, Dong-Sheng Cao, Hong-Yu Miao, Shao Liu, Bai-Chuan Deng, Yong-Huan Yun, Ning-Ning Wang, Ai-Ping Lu, Wen-Bin Zeng, Alex F. Chen, ChemDes: an integrated web-based platform for molecular descriptor and fingerprint computation, Journal of Cheminformatics, 7, (2015), 60 https://doi.org/10.1186/s13321-015-0109-z
  16. Neni Frimayanti, Vannajan Sanghiran Lee, Sharifuddin M. Zain, Habibah A. Wahab, Noorsaadah Abd. Rahman, 2D, 3D-QSAR, and pharmacophore studies on thiazolidine-4-carboxylic acid derivatives as neuraminidase inhibitors in H3N2 influenza virus, Medicinal Chemistry Research, 23, 3, (2014), 1447-1453 https://doi.org/10.1007/s00044-013-0750-x
  17. Madhulata Kumari, Subhash Chandra, Neeraj Tiwari, Naidu Subbarao, 3D QSAR, pharmacophore and molecular docking studies of known inhibitors and designing of novel inhibitors for M18 aspartyl aminopeptidase of Plasmodium falciparum, BMC Structural Biology, 16, (2016), 12 https://doi.org/10.1186/s12900-016-0063-7
  18. Yongmei Pan, Yanli Wang, Stephen H. Bryant, Pharmacophore and 3D-QSAR Characterization of 6-Arylquinazolin-4-amines as Cdc2-like Kinase 4 (Clk4) and Dual Specificity Tyrosine-phosphorylation-regulated Kinase 1A (Dyrk1A) Inhibitors, Journal of Chemical Information and Modeling, 53, 4, (2013), 938-947 https://doi.org/10.1021/ci300625c
  19. Rathinasabapathy Pushpalatha, Subramanian Selvamuthukumar, Duraisamy Kilimozhi, Comparative Insilico Docking Analysis of Curcumin and Resveratrol on Breast Cancer Proteins and their Synergistic Effect on MCF-7 Cell Line, Journal of Young Pharmacists, 9, 4, (2017), 480-485 https://dx.doi.org/10.5530/jyp.2017.9.94
  20. F. Frimayanti, Benni Iskandar, Marzieh Yaeghoobi, Heh Choon Han, Sharifuddin M. Zain, Rohana Yusof, Noorsaadah Abdul Rahman, Docking, synthesis and bioassay studies of imine derivatives as potential inhibitors for dengue NS2B/NS3 serine protease, Asian Pacific Journal of Tropical Disease, 7, 12, (2017), 792-796 https://doi.org/10.12980/apjtd.7.2017D7-177
  21. N. Frimayanti, M. Yaeghoobi, I. Ikhtiarudin, D. R. W. Putri, H. Namavar, F. S. Bitaraf, Insight on the In Silico Study and Biological Activity Assay of Chalcone-Based 1, 5-Benzothiazepines as Potential Inhibitor for Breast Cancer MCF7, Chiang Mai University Journal of Natural Sciences, 20, 1, (2021), e2021019 https://doi.org/10.12982/CMUJNS.2021.019
  22. Lu Zhou, Jiewei Zhu, Yifan Zhao, Honghe Ma, A molecular dynamics study on thermal conductivity enhancement mechanism of nanofluids – Effect of nanoparticle aggregation, International Journal of Heat and Mass Transfer, 183, (2022), 122124 https://doi.org/10.1016/j.ijheatmasstransfer.2021.122124
  23. Belal O. Al-Najjar, Ashok K. Shakya, Fadi G. Saqallah, Rana Said, Pharmacophore modeling and 3D-QSAR studies of 15-hydroxyprostaglandin dehydrogenase (15-PGDH) inhibitors, (2017),
  24. Maryam Abbasi, Hojjat Sadeghi-Aliabadi, Massoud Amanlou, Prediction of new Hsp90 inhibitors based on 3,4-isoxazolediamide scaffold using QSAR study, molecular docking and molecular dynamic simulation, DARU Journal of Pharmaceutical Sciences, 25, (2017), 17 https://doi.org/10.1186/s40199-017-0182-0
  25. Neni Frimayanti, Marzieh Yaeghoobi, Hamid Namavar, Mashitoh Cindy Utari, Meiriza Djohari, Cindy Oktaviana Laia, In silico analysis approach for screening new agents for breast cancer inhibitors based on 1, 5-benzothiazepine, Pharmaceutical Sciences Asia, 49, 5, (2022), 446-453 https://doi.org/10.29090/psa.2022.05.22.001
  26. Fumiyoshi Yamashita, Mitsuru Hashida, In Silico Approaches for Predicting ADME Properties of Drugs, Drug Metabolism and Pharmacokinetics, 19, 5, (2004), 327-338 https://doi.org/10.2133/dmpk.19.327
  27. Christopher A. Lipinski, Franco Lombardo, Beryl W. Dominy, Paul J. Feeney, Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings, Advanced Drug Delivery Reviews, 64, (2012), 4-17 https://doi.org/10.1016/j.addr.2012.09.019

Last update:

No citation recorded.

Last update: 2024-11-22 02:18:08

No citation recorded.